Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Inês Vaz-Luis
Based on 28 articles published since 2008
||||
Expertise Level
The expertise of Inês Vaz-Luis ranks in the
  • Top 0.4%
  • ... of 263,330 published authors worldwide on Breast Neoplasms
  • ... from 2008 through 2019
  • ... based on contributions to 28 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
Expert badge
similar to this:
 
Aliases Vaz-Luís, Inês   ·   Vaz-Luis, I   ·   Vaz-Luis, Ines   ·   Vaz-Luis, Inês
Work Locations
Details
Most likely:    Harvard University   Contact    
2018
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · INSERM UMR981 Department of Medical Oncology, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. · Pubmed 29358778
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Medical Oncology, INSERM U981, Institut Gustave Roussy, Villejuif, France. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 29332137
  • Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Registo Oncológico Regional do Sul, Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Hospitais CUF Lisboa, R. Mário Botas, 1998-018 Lisbon, Portugal. · Hospital da Luz, Avenida Lusíada, 100, 1500-650 Lisbon, Portugal. · Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal. · Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Institut Gustave Roussy, Unit INSERM 981, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Pubmed 29131988
2017
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Memorial Sloan Kettering Cancer Center, New York, New York. · Mayo Clinic, Scottsdale, Arizona. · Pubmed 28323331
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts · Academic Unit of Medical Oncology, IRCCS San Martino University Hospital – IST National Cancer Research Institute, Genoa, Italy · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts · Department of Medical Oncology and Unit INSERM 981, Institut Gustave Roussy, Paris, France · Pubmed 28275032
2016
  • From Department of Medical Oncology and Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, Massachusetts; Oncoclinicas, Sao Paulo, Brazil; Department of General Surgery, Istanbul Medical School, Istanbul, Turkey; and Department of Surgery, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 27956536
  • Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Oncoclinicas do Brasil, Rua Maranhão 569/4, São Paulo 01240-001, Brazil. · Department of Surgery, Dana Farber/Brigham and Women's Cancer Center, 75 Francis Street, Boston, MA 02115, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Pubmed 27721193
  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27631400
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 27484879
  • Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal. Electronic address: · Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal. · Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal. · Registo Oncológico Regional do Sul, Lisbon, Portugal. · Hospitais CUF Lisboa, Lisbon, Portugal. · Hospital da Luz, Lisbon, Portugal. · Instituto Português de Oncologia F. G. de Lisboa, Lisbon, Portugal. · Fundação Champalimaud, Lisbon, Portugal. · Dana-Farber Cancer Institute, Boston, USA. · Pubmed 27468923
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Center for Community-Based Research, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Society and Behavioral Sciences, Harvard School of Public Health, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 27339067
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Academic Unit of Medical Oncology, IRCCS AOU San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Surgical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 27271765
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Massachusetts General Hospital, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26868124
  • Yasuaki Sagara, Melissa Anne Mallory, Fatih Aydogan, and Mehra Golshan, Brigham and Women's Hospital · Yasuaki Sagara, Harvard T.H. Chan School of Public Health · Rachel A. Freedman, Ines Vaz-Luis, Stephen DeSantis, and William T. Barry, Dana-Farber Cancer Institute, Boston, MA · Stephanie M. Wong, McGill University Health Centre, Montreal, Quebec, Canada · and Fatih Aydogan, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey. · Pubmed 26834064
2015
  • Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA · Pubmed 26443566
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 26022349
  • Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 25893416
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Division of, Medical Oncology, Department of Medicine, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Medical Oncology, Baptist Cancer Center, Memphis, Tennessee. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25757412
  • Dana-Farber Cancer Institute, Boston, MA. · Dana-Farber Cancer Institute, Boston, MA · Pubmed 25403214
2014
  • Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute · Beverly Moy, Massachusetts General Hospital, Boston, MA · Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal · Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte · Hope S. Rugo, University of California, San Francisco, San Francisco, CA · Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY · Stephen B. Edge, Baptist Cancer Center, Memphis, TN · and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24888816
  • Ines Vaz-Luis, Nancy U. Lin, Eric P. Winer, and Rachel A. Freedman, Dana-Farber Cancer Institute · Nancy L. Keating, Harvard Medical School · Nancy L. Keating and Huichuan Lii, Brigham and Women's Hospital, Boston, MA · and Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal. · Pubmed 24516021
2013
  • Department of Medical Oncology, Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA 02215 USA. · Pubmed 23022997
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 24113744
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Breast Oncology Center, Boston, MA 02215, USA. · Pubmed 23829891
2014
  • Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA, · Pubmed 24756187
Probable:    Institut Gustave Roussy      
2018
  • a Department of Medical Oncology , Gustave Roussy , Villejuif , France. · b Medical Oncology , Institute of Oncology and Breast Unit of Southern Switzerland , Bellinzona , Switzerland. · Pubmed 30188738
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · INSERM UMR981 Department of Medical Oncology, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. · Pubmed 29358778
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Medical Oncology, INSERM U981, Institut Gustave Roussy, Villejuif, France. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 29332137
  • Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Registo Oncológico Regional do Sul, Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Hospitais CUF Lisboa, R. Mário Botas, 1998-018 Lisbon, Portugal. · Hospital da Luz, Avenida Lusíada, 100, 1500-650 Lisbon, Portugal. · Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal. · Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Institut Gustave Roussy, Unit INSERM 981, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Pubmed 29131988
2017
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts · Academic Unit of Medical Oncology, IRCCS San Martino University Hospital – IST National Cancer Research Institute, Genoa, Italy · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts · Department of Medical Oncology and Unit INSERM 981, Institut Gustave Roussy, Paris, France · Pubmed 28275032
  • Departments of Medical Oncology. · Department of Medical Oncology, Institute Gustave Roussy, Villejuif, France. · Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Departments of Medical Oncology · Pubmed 28242790
Probable:    INSERM France      
2018
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · INSERM UMR981 Department of Medical Oncology, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. · Pubmed 29358778
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Medical Oncology, INSERM U981, Institut Gustave Roussy, Villejuif, France. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 29332137
  • Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Registo Oncológico Regional do Sul, Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Hospitais CUF Lisboa, R. Mário Botas, 1998-018 Lisbon, Portugal. · Hospital da Luz, Avenida Lusíada, 100, 1500-650 Lisbon, Portugal. · Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal. · Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Institut Gustave Roussy, Unit INSERM 981, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Pubmed 29131988
2017
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts · Academic Unit of Medical Oncology, IRCCS San Martino University Hospital – IST National Cancer Research Institute, Genoa, Italy · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts · Department of Medical Oncology and Unit INSERM 981, Institut Gustave Roussy, Paris, France · Pubmed 28275032
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 28 total) written by Inês Vaz-Luis about Breast Neoplasms:

  • Managing side effects in adjuvant endocrine therapy for breast cancer. 2018
  • Exogenous reproductive hormone use in breast cancer survivors and previvors. 2018
  • Variation in guideline-concordant care for elderly patients with metastatic breast cancer in the United States. 2018
  • Treatment adoption and relative effectiveness of aromatase inhibitors compared to tamoxifen in early breast cancer: A multi-institutional observational study. 2018
  • Survival benefit needed to undergo chemotherapy: Patient and physician preferences. 2017
  • Patterns of Utilization of Imaging Studies and Serum Tumor Markers Among Patients With De Novo Metastatic Breast Cancer. 2017
  • Factors Associated with Early Mortality Among Patients with 2017
  • Factors Associated With Delays in Chemotherapy Initiation Among Patients With Breast Cancer at a Comprehensive Cancer Center. 2016
  • Variation in the use of granulocyte-colony stimulating factor for dose dense paclitaxel: A single institution retrospective study. 2016
  • Optimizing Adjuvant Chemotherapy and Surgery for Early- and Late-Stage Breast Cancer. 2016
Show List of Full Article Records
Google Searches

Learn more about Inês Vaz-Luis using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Harvard University
Institut Gustave Roussy
INSERM France
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Harvard University
2018
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · INSERM UMR981 Department of Medical Oncology, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. · Pubmed 29358778
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Medical Oncology, INSERM U981, Institut Gustave Roussy, Villejuif, France. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 29332137
  • Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Registo Oncológico Regional do Sul, Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Hospitais CUF Lisboa, R. Mário Botas, 1998-018 Lisbon, Portugal. · Hospital da Luz, Avenida Lusíada, 100, 1500-650 Lisbon, Portugal. · Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal. · Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Institut Gustave Roussy, Unit INSERM 981, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Pubmed 29131988
2017
  • Dana-Farber Cancer Institute, Boston, Massachusetts. · Massachusetts General Hospital, Boston, Massachusetts. · Indiana University Simon Cancer Center, Indianapolis, Indiana. · Memorial Sloan Kettering Cancer Center, New York, New York. · Mayo Clinic, Scottsdale, Arizona. · Pubmed 28323331
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts · Academic Unit of Medical Oncology, IRCCS San Martino University Hospital – IST National Cancer Research Institute, Genoa, Italy · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts · Department of Medical Oncology and Unit INSERM 981, Institut Gustave Roussy, Paris, France · Pubmed 28275032
2016
  • From Department of Medical Oncology and Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, Massachusetts; Oncoclinicas, Sao Paulo, Brazil; Department of General Surgery, Istanbul Medical School, Istanbul, Turkey; and Department of Surgery, Dana-Farber Cancer Institute/Brigham and Women's Hospital, Boston, Massachusetts. · Pubmed 27956536
  • Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. · Oncoclinicas do Brasil, Rua Maranhão 569/4, São Paulo 01240-001, Brazil. · Department of Surgery, Dana Farber/Brigham and Women's Cancer Center, 75 Francis Street, Boston, MA 02115, USA. · Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA. Electronic address: · Pubmed 27721193
  • Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts. · Pubmed 27631400
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA. · Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 27484879
  • Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal. Electronic address: · Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal. · Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal; Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Lisbon, Portugal. · Registo Oncológico Regional do Sul, Lisbon, Portugal. · Hospitais CUF Lisboa, Lisbon, Portugal. · Hospital da Luz, Lisbon, Portugal. · Instituto Português de Oncologia F. G. de Lisboa, Lisbon, Portugal. · Fundação Champalimaud, Lisbon, Portugal. · Dana-Farber Cancer Institute, Boston, USA. · Pubmed 27468923
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Center for Community-Based Research, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Society and Behavioral Sciences, Harvard School of Public Health, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Pubmed 27339067
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Academic Unit of Medical Oncology, IRCCS AOU San Martino University Hospital, IST National Cancer Research Institute, Genoa, Italy. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Health Care Policy, Harvard Medical School, Boston, MA, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, MA, USA. · Department of Surgical Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 27271765
  • Dana-Farber Cancer Institute, Boston, MA, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · San Francisco Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA, USA. · Roswell Park Cancer Institute, Buffalo, NY, USA. · Massachusetts General Hospital, Boston, MA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Pubmed 26868124
  • Yasuaki Sagara, Melissa Anne Mallory, Fatih Aydogan, and Mehra Golshan, Brigham and Women's Hospital · Yasuaki Sagara, Harvard T.H. Chan School of Public Health · Rachel A. Freedman, Ines Vaz-Luis, Stephen DeSantis, and William T. Barry, Dana-Farber Cancer Institute, Boston, MA · Stephanie M. Wong, McGill University Health Centre, Montreal, Quebec, Canada · and Fatih Aydogan, Cerrahpasa Medical School, Istanbul University, Istanbul, Turkey. · Pubmed 26834064
2015
  • Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA · Pubmed 26443566
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 26022349
  • Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. · Pubmed 25893416
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Division of, Medical Oncology, Department of Medicine, University of California at San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California. · Department of Medical Oncology, Baptist Cancer Center, Memphis, Tennessee. · Department of Medical Oncology, Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Pubmed 25757412
  • Dana-Farber Cancer Institute, Boston, MA. · Dana-Farber Cancer Institute, Boston, MA · Pubmed 25403214
2014
  • Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute · Beverly Moy, Massachusetts General Hospital, Boston, MA · Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal · Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte · Hope S. Rugo, University of California, San Francisco, San Francisco, CA · Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY · Stephen B. Edge, Baptist Cancer Center, Memphis, TN · and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24888816
  • Ines Vaz-Luis, Nancy U. Lin, Eric P. Winer, and Rachel A. Freedman, Dana-Farber Cancer Institute · Nancy L. Keating, Harvard Medical School · Nancy L. Keating and Huichuan Lii, Brigham and Women's Hospital, Boston, MA · and Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal. · Pubmed 24516021
2013
  • Department of Medical Oncology, Breast Oncology Center, Dana-Farber Cancer Institute, Boston, MA 02215 USA. · Pubmed 23022997
  • Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 24113744
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Breast Oncology Center, Boston, MA 02215, USA. · Pubmed 23829891
2014
  • Department of Medical Oncology, Dana Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA, · Pubmed 24756187
Institut Gustave Roussy
2018
  • a Department of Medical Oncology , Gustave Roussy , Villejuif , France. · b Medical Oncology , Institute of Oncology and Breast Unit of Southern Switzerland , Bellinzona , Switzerland. · Pubmed 30188738
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · INSERM UMR981 Department of Medical Oncology, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. · Pubmed 29358778
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Medical Oncology, INSERM U981, Institut Gustave Roussy, Villejuif, France. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 29332137
  • Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Registo Oncológico Regional do Sul, Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Hospitais CUF Lisboa, R. Mário Botas, 1998-018 Lisbon, Portugal. · Hospital da Luz, Avenida Lusíada, 100, 1500-650 Lisbon, Portugal. · Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal. · Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Institut Gustave Roussy, Unit INSERM 981, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Pubmed 29131988
2017
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts · Academic Unit of Medical Oncology, IRCCS San Martino University Hospital – IST National Cancer Research Institute, Genoa, Italy · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts · Department of Medical Oncology and Unit INSERM 981, Institut Gustave Roussy, Paris, France · Pubmed 28275032
  • Departments of Medical Oncology. · Department of Medical Oncology, Institute Gustave Roussy, Villejuif, France. · Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Departments of Medical Oncology · Pubmed 28242790
INSERM France
2018
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, Massachusetts 02215, USA. · INSERM UMR981 Department of Medical Oncology, Institut Gustave Roussy, 114 Rue Edouard Vaillant, 94800, Villejuif, France. · Pubmed 29358778
  • Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Department of Medical Oncology, INSERM U981, Institut Gustave Roussy, Villejuif, France. · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, MA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. · Pubmed 29332137
  • Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal; Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Hospital de Santa Maria, Centro Hospitalar de Lisboa Norte, Av. Prof. Egas Moniz, 1649-035 Lisbon, Portugal. · Registo Oncológico Regional do Sul, Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Hospitais CUF Lisboa, R. Mário Botas, 1998-018 Lisbon, Portugal. · Hospital da Luz, Avenida Lusíada, 100, 1500-650 Lisbon, Portugal. · Instituto Português de Oncologia F. G. de Lisboa, R. Prof. Lima Basto, 1099-023 Lisbon, Portugal. · Fundação Champalimaud, Av. Brasília, 1400-038 Lisbon, Portugal. · Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. · Institut Gustave Roussy, Unit INSERM 981, 114 Rue Edouard Vaillant, 94800 Villejuif, France; Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02215, USA. Electronic address: · Pubmed 29131988
2017
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts · Academic Unit of Medical Oncology, IRCCS San Martino University Hospital – IST National Cancer Research Institute, Genoa, Italy · Department of Biostatistics & Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts · Department of Medical Oncology and Unit INSERM 981, Institut Gustave Roussy, Paris, France · Pubmed 28275032
Unspecified
2017
  • Departments of Medical Oncology. · Department of Medical Oncology, Institute Gustave Roussy, Villejuif, France. · Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts, USA. · Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. · Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. · Departments of Medical Oncology · Pubmed 28242790
Miscellaneous institutions in Lisboa
2014
  • Ines Vaz-Luis, Melissa E. Hughes, Harold J. Burstein, Jane C. Weeks, Eric P. Winer, and Nancy U. Lin, Dana-Farber Cancer Institute · Beverly Moy, Massachusetts General Hospital, Boston, MA · Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal · Rebecca A. Ottesen and Rizvan Mamet, City of Hope, Duarte · Hope S. Rugo, University of California, San Francisco, San Francisco, CA · Stephen B. Edge, Roswell Park Cancer Institute, Buffalo, NY · Stephen B. Edge, Baptist Cancer Center, Memphis, TN · and Ana M. Gonzalez-Angulo and Richard L. Theriault, University of Texas MD Anderson Cancer Center, Houston, TX. · Pubmed 24888816
  • Ines Vaz-Luis, Nancy U. Lin, Eric P. Winer, and Rachel A. Freedman, Dana-Farber Cancer Institute · Nancy L. Keating, Harvard Medical School · Nancy L. Keating and Huichuan Lii, Brigham and Women's Hospital, Boston, MA · and Ines Vaz-Luis, Instituto de Medicina Molecular, Lisbon, Portugal. · Pubmed 24516021
Yearly article counts 043953310000
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.